References
- Jennette JC. Overview of the 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603–606.
- Ponte C, Águeda AF, Luqmani RA, et al. Clinical features and structured clinical evaluation of vasculitis. Best practice & research. Clin Rheumatol. 2018;32(1):31–51.
- Camara-Lemarroy CR, Infante-Valenzuela A, Villareal-Montemayor HJ, et al. Eosinophilic granulomatosis with polyangiitis presenting as acute polyneuropathy mimicking Guillain-Barre Syndrome. Case Rep Neurol Med. 2015;2015:981439.
- Yoo IH, Choi ST, Choi SH, et al. Eosinophilic granulomatosis with polyangiitis presented as acute polyneuropathy and cerebral vasculitis. Exp Neurobiol. 2017;26(3):168–171.
- Riva N, Cerri F, Butera C, et al. Churg strauss syndrome presenting as acute neuropathy resembling Guillain Barre syndrome: case report. J Neurol. 2008;255(11):1843–1844.
- De Toni Franceschini L, Amadio S, Scarlato M, et al. A fatal case of Churg-Strauss syndrome presenting with acute polyneuropathy mimicking Guillain-Barre syndrome. Neurol Sci. 2011;32(5):937–940. .
- Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016;388(10045):717–727.
- Nguyen TP, Taylor RS. Guillain Barre Syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing. StatPearls Publishing LLC; 2019.
- Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain-Barre Syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671–683. .
- Wijdicks EF, Klein CJ. Guillain-Barre Syndrome. Mayo Clin Proc. 2017;92(3):467–479.
- Berti A, Dejaco C. Update on the epidemiology, risk factors, and outcomes of systemic vasculitides. Best practice & research. Clin Rheumatol. 2018;32(2):271–294.
- Arman F, Barsoum M, Selamet U, et al. Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment. Int J Nephrol Renovasc Dis. 2018;11:313–319.
- Geetha D, Jefferson JA. ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis. 2019;75(1):124–137.
- Greco A, Rizzo MI, De Virgilio A, et al. Churg-Strauss syndrome. Autoimmun Rev. 2015;14(4):341–348.
- Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545–553.
- Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheumatism. 1990;33(8):1094–1100.
- Chakraborty RK, Aeddula NR. Churg Strauss Syndrome (Allergic Granulomatosis). StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC; 2019.
- Watts RA, Robson J. Introduction, epidemiology and classification of vasculitis. Best practice & research. Clin Rheumatol. 2018;32(1):3–20.
- Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583–1594.
- Geetha D, Jin Q, Scott J, et al. Comparisons of guidelines and recommendations on managing antineutrophil cytoplasmic antibody-associated vasculitis. Kidney Int Rep. 2018;3(5):1039–1049.
- Derebail VK, Falk RJ. ANCA-associated vasculitis - refining therapy with plasma exchange and glucocorticoids. N Engl J Med. 2020;382(7):671–673.
- Tuin J, Stassen PM, Bogdan DI, et al. Mycophenolate mofetil versus cyclophosphamide for the induction of remission in nonlife-threatening relapses of antineutrophil cytoplasmic antibody-associated vasculitis: randomized, controlled trial. Clin J Am Soc Nephrol. 2019;14(7):1021–1028.